PATENT CLAIM ANALYSIS

Application Number: 15756774
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["424", "196110"]

Abstract:
A vaccine composition is disclosed. The vaccine composition comprises: (a) a therapeutically effective amount of an influenza virus-like particle (VLP) comprising: (i) influenza M1, influenza M2, influenza hemagglutinin (HA), and influenza neuraminidase (NA) proteins; (b) Foot-and-mouth disease virus (FMDV) capsid protein VP3, recombinant FMDV VP3 (rVP3), VP3 peptide, or SUMO VP3; and (c) alum. Also disclosed is use of a vaccine composition according to the invention in the manufacture of a medicament for inducing an immunogenic response in a subject in need thereof.

Claim (Index 17):
A method of formulating a vaccine composition as claimed in  claim 2 , comprising:\n adding the therapeutically effective amount of the influenza VLP to the VP3, rVP3, VP3 peptide, or SUMO VP3 and alum.

Metadata:
- Claim Count in Document: 18.0
- Percentile: 90.0
- Lexical Diversity: 1.78125
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13890711', '13297125', '15454820', '15608532', '14149365']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7560260487236825
- 35 USC 102 Novelty (BERT): 0.5332020049833248
- Combined Prediction Score: 0.7337436443496468
- Mean Citation Score: 369.34353
- Max Citation Score: 374.46396
- Similarity Product: 266.97443411318784

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test